221 related articles for article (PubMed ID: 17849117)
1. Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients.
Wierzbowska A; Robak T; Krawczyńska A; Pluta A; Wrzesień-Kuś A; Cebula B; Robak E; Smolewski P
Ann Hematol; 2008 Feb; 87(2):97-106. PubMed ID: 17849117
[TBL] [Abstract][Full Text] [Related]
2. Circulating endothelial cells in patients with acute myeloid leukemia.
Wierzbowska A; Robak T; Krawczyńska A; Wrzesień-Kuś A; Pluta A; Cebula B; Smolewski P
Eur J Haematol; 2005 Dec; 75(6):492-7. PubMed ID: 16313261
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric detection of circulating endothelial cells and endothelial progenitor cells in healthy subjects.
Mariucci S; Rovati B; Bencardino K; Manzoni M; Danova M
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e40-8. PubMed ID: 20088999
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?
Aswald JM; Wang XH; Aswald S; Lutynski A; Minden MD; Messner HA; Keating A
Cytometry B Clin Cytom; 2006 Nov; 70(6):379-90. PubMed ID: 16977635
[TBL] [Abstract][Full Text] [Related]
5. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
[TBL] [Abstract][Full Text] [Related]
6. Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.
Twardowski PW; Smith-Powell L; Carroll M; VanBalgooy J; Ruel C; Frankel P; Synold TW
Cancer Invest; 2008 Feb; 26(1):53-9. PubMed ID: 18181046
[TBL] [Abstract][Full Text] [Related]
7. Relation of cell viability and apoptosis with clinical remission following induction chemotherapy in ALL and AML.
Bhushan B; Ahuja D; Verma S; Saluja S; Siddiqui S; Kapur S
J Exp Clin Cancer Res; 2007 Sep; 26(3):313-21. PubMed ID: 17987789
[TBL] [Abstract][Full Text] [Related]
8. Remission induction chemotherapy induces in vivo caspase-dependent apoptosis in bone marrow acute myeloid leukemia blast cells and spares lymphocytes.
Vial JP; Tabrizi R; Pigneux A; Lacombe F; Praloran V; Belloc F
Cytometry B Clin Cytom; 2006 May; 70(3):115-23. PubMed ID: 16572429
[TBL] [Abstract][Full Text] [Related]
9. Endostatin serum level in acute myeloid leukemia.
Wrobel T; Mazur G; Kapelko K; Kuliczkowski K
Neoplasma; 2005; 52(2):182-4. PubMed ID: 15800718
[TBL] [Abstract][Full Text] [Related]
10. Circulating endothelial and endothelial progenitor cells in patients with severe sepsis.
Schlichting DE; Waxman AB; O'Brien LA; Wang T; Naum CC; Rubeiz GJ; Um SL; Williams M; Yan SC
Microvasc Res; 2011 Mar; 81(2):216-21. PubMed ID: 21130783
[TBL] [Abstract][Full Text] [Related]
11. Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay.
Jacques N; Vimond N; Conforti R; Griscelli F; Lecluse Y; Laplanche A; Malka D; Vielh P; Farace F
J Immunol Methods; 2008 Sep; 337(2):132-43. PubMed ID: 18662694
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of prognostic variables in childhood acute myeloid leukemia].
Gu LJ; Tie LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Ye H; Wang YP; Dong L
Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):10-3. PubMed ID: 16732931
[TBL] [Abstract][Full Text] [Related]
13. Novel therapeutic agents in acute myeloid leukemia.
Stone RM
Exp Hematol; 2007 Apr; 35(4 Suppl 1):163-6. PubMed ID: 17379102
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
15. Increased circulating endothelial progenitor cells in septic patients: correlation with survival.
Rafat N; Hanusch C; Brinkkoetter PT; Schulte J; Brade J; Zijlstra JG; van der Woude FJ; van Ackern K; Yard BA; Beck GCh
Crit Care Med; 2007 Jul; 35(7):1677-84. PubMed ID: 17522579
[TBL] [Abstract][Full Text] [Related]
16. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus.
Robak E; Kierstan M; Cebula B; Krawczynska A; Sysa-Jedrzejowska A; Wierzbowska A; Smolewski P; Robak T
Lupus; 2009 Apr; 18(4):332-41. PubMed ID: 19276301
[TBL] [Abstract][Full Text] [Related]
17. [Circulating endothelial cells, endothelial precursors, VEGF and bFGF concentrations in patients with acute leukemias, lymphomas and myelomas].
Poreba M; Jaźwiec B; Kuliczkowski K; Poreba R
Pol Arch Med Wewn; 2005 Jan; 113(1):27-34. PubMed ID: 16130598
[TBL] [Abstract][Full Text] [Related]
18. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis.
Graf M; Reif S; Kröll T; Hecht K; Nuessler V; Schmetzer H
Am J Hematol; 2006 Apr; 81(4):227-35. PubMed ID: 16550517
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia.
Rizzieri DA; O'Brien JA; Broadwater G; Decastro CM; Dev P; Diehl L; Beaven A; Lagoo A; Gockerman JP; Chao NJ; Moore JO
Cancer; 2009 Jul; 115(13):2922-9. PubMed ID: 19452542
[TBL] [Abstract][Full Text] [Related]
20. Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy.
Erdbruegger U; Woywodt A; Kirsch T; Haller H; Haubitz M
Am J Kidney Dis; 2006 Oct; 48(4):564-70. PubMed ID: 16997052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
